Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-1995 | 03-1994 | 03-1993 | |
| Cash Flows From Operating Activities | |||
| Net Income | 520 | 320 | 180 |
| Depreciation Amortization | 180 | 50 | 30 |
| Other Operating Activity | -270 | -80 | -100 |
| Operating Cash Flow | $430 | $290 | $110 |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | -1,470 | -1,320 | -30 |
| Investing Cash Flow | $-1,470 | $-1,320 | $-30 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 70 | 1,420 | 250 |
| Financing Cash Flow | $70 | $1,420 | $250 |
| Beginning Cash Position | 970 | 580 | 250 |
| End Cash Position | 7 | 970 | 580 |
| Net Cash Flow | $-970 | $390 | $330 |
| Free Cash Flow | |||
| Operating Cash Flow | 430 | 290 | 110 |
| Free Cash Flow | 430 | 290 | 110 |